Transient receptor potential vanilloid type-1 channel (TRPV1) is a non-selective cation channel with a preference for calcium ions that is able to sense a vast range of endogenous physical and chemical stimuli and plays an important role in transducing the sensations of noxious heat and pain signaling. Recent studies showed that TRPV1 is widely expressed in different tissues and organs beyond the sensory nerves and has multiple biological effects that are involved in functional regulation in the pancreas, blood vessel, adipose tissue and liver. To further understand the link between TRPV1 and cardiometabolic diseases, we reviewed the role of TRPV1 in hypertension, diabetes, obesity, and dyslipidemia. This review provides new insights into the involvement of TRPV1 channels in the pathogenesis of cardiometabolic disorders and implicates this channel as a potential therapeutic target for the management of cardiometabolic diseases. 
Introduction
Cardiovascular disease (CVD) remains by far the leading cause of morbidity and mortality in the world. 1, 2) Risk factors for CVD and type 2 diabetes often cluster, including abdominal obesity, hypertension, insulin resistance, hyperglycemia, and dyslipidemia, and are called cardiometabolic risk factors (CMRFs). 3, 4) When occurring together, CMRFs increase a patient's chance for developing diabetes, heart disease, or stroke. Modifications of CMRFs seem to have a beneficial effect on clinical outcomes, but management guidelines for CMRFs are still not available at the present time.
For managing both long-and short-term risk, lifestyle therapies are the first-line interventions to reduce the cardiometabolic risk factors. In the American Heart Association 2006 Diet and Lifestyle Recommendations for Cardiovascular Diseases Risk Reduction, it was recommended to balance caloric intake; consume a diet rich in vegetables and fruits; choose whole-grain, high-fiber foods; consume oily fish, low salt and high potassium; and limit intake of saturated fat and beverages and foods with added sugars. 5) A recent report showed that a reduction of salt (3 g per day) lowered blood pressure 4-6 mm Hg in the entire study population and 6-9 mm Hg in African Ameri- Fig. 1 . Transient receptor potential vanilloid type-1 channel (TRPV1) has six transmembrane domains and a short, poreforming hydrophobic stretch between the fifth and sixth transmembrane domains. Capsaicin binding to TRPV1 triggers an increase in intracellular calcium. When this occurs in sensory nerves, it promotes the sensation of pain, inflammation, and local heat. TRPV1 is also activated by noxious heat ( > 43°C) and acid (pH < 5.9), voltage, and various lipids.
cans. Reducing dietary salt by 3 g per day is projected
to reduce the annual number of new cases of coronary heart disease (CHD), stroke, and myocardial infarction. This benefit is similar to the administration of anti-hypertensive drugs or statins. 6) Capsaicin is the pungent ingredient in hot chili peppers.
Recently, some evidence showed that chronic treatment of red peppers can decrease abdominal fat and increase fat oxidation, and long-term consumption of spicy foods decreased the incidence of cardiovascular events. [7] [8] [9] In recent years, our studies showed that dietary capsaicin, acting as a transient receptor potential vanilloid type-1 channel (TRPV1) agonist, can prevent obesity and lower blood pressure in spontaneous hypertensive rats (SHR). 10, 11) This evidence implicates capsaicin as a potential therapeutic agent for the management of cardiometabolic diseases.
The target for capsaicin is the capsaicin receptor, also called TRPV1. TRPV1 was first cloned by David Julius in 1997. 12) This channel is a member of the TRP superfamily and a nonselective cation channel with high calcium permeability; it has six transmembrane domains and a short, pore-forming hydrophobic stretch between the fifth and sixth transmembrane domains. 13) Capsaicin binding to TRPV1 triggers an increase in intracellular calcium, which causes the release of several neuropeptides, such as substance P and calcitonin gene-related peptide (CGRP). 14) When this occurs in sensory nerves, it promotes the sensation of pain, inflammation, and of the local heat. TRPV1
is also activated by noxious heat (> 43°C) and acid (pH < 5.9), voltage, and various lipids (Fig. 1) . Experiments have demonstrated that TRPV1 is widely expressed in different tissues and organs beyond sensory nerves, such as pancreas, blood vessels, adipose tissue and liver, and is well recognized to play roles in pain sensation and thermosensation, apoptosis, regulation of bladder function, taste, and neurogenic inflammation. 13, 15) Recent emerging evidence shows that TRPV1 plays an important role in metabolic regulation and vascular function and exerts beneficial effects on cardiometabolic diseases. In this review, we will focus on its role in cardiometabolic diseases.
TRPV1 and vascular tone
TRPV1 channels are densely distributed in the myocardium and the circulatory system, not only in sensory nerves but also in other cell types, such as the vascular smooth muscle cells and endothelial cells. 10, 16, 17) Data from both animal models and patients indicate that TRPV1 channels play an important role in regulating vascular tone.
It is well known that capsaicin-sensitive sensory nerves 
TRPV1 and hypertension
A change of peripheral vascular resistance is a key factor regulating blood pressure. As described before, vasoconstrictors and vasodilators from sympathetic and capsaicin-sensitive sensory nerves play important roles in regulating blood pressure. 19) Recent studies have shown that the TRPV1 channel is associated with the pathogenesis of hypertension. 26) Activation of TRPV1 has been shown to exert antihypertensive effects through stimulating the release of CGRP from capsaicin-sensitive sensory nerves or NO from endothelial cells.
It has been shown that plasma concentrations of CGRP rise transiently after acute administration of capsaicin in adult rats accompanied by a decrease in blood pressure. 19) Hypotensive effects were also obtained with the administration of TRPV1 endogenous ligand anandamide, which were almost completely prevented in the presence of capsazepine, the antagonist of TRPV1. 27 TRPV1 channels are also involved in the regulation of sodium excretion, which is critical for the control of blood pressure, especially in cases of salt-sensitive hypertension.
Wang et al. 29) found that high salt (HS) intake increased baseline mean arterial pressure. Capsazepine, a selective TRPV1 antagonist, caused a greater increase in blood pressure in HS-treated compared to normal salt (NS)-treated rats. HS intake increases production of anandamide, which may serve as an endovanilloid to activate TRPV1, leading to the release of CGRP to blunt salt-induced increases in blood pressure. These data support the notion that TRPV1 may act as a molecular target for salt-induced elevation of endovanilloid compounds to regulate blood pressure.
TRPV1 receptor is activated and its expression upregulated during HS intake in Dahl salt-resistant (DR) rats, which acts to prevent salt-induced increases in blood pressure.
In contrast, TRPV1 expression and function are impaired in Dahl salt-sensitive (DS) rats, which renders DS rats sensitive to salt load in terms of blood pressure regulation.
Our data revealed consumption of a HS diet elevated nocturnal blood pressure in mice. These effects were associated with increased superoxide anion generation and reduced NO levels in mesenteric vessels in mice on a HS diet. Chronic dietary capsaicin reduced nocturnal hypertension, in part, by preventing the generation of superoxide anions and NO reduction of mesenteric arteries through vascular TRPV1 activation. 25) TRPV1 and cardiac protection Cardioprotection by IPC against I/R injury is lost in TRPV1-/-hearts, and the underlying mechanism is partly associated with the decreased CGRP and SP release due to the impairment of TRPV1 receptor.
34)
TRPV1 and diabetes channels in genetic and non-genetic diabetic models. 44) Several findings suggest that capsaicin-sensitive nerves regulate glucose tolerance by improving insulin resistance through a mechanism that is independent of insulin release. 41, 45) Because TRPV1 + fibers also innervate insulin target organs, such as skeletal muscle and liver, TRPV1
in these organs might also be involved in glucose tolerance. In addition, TRPV1 has recently been discovered in non-neuronal cells, including myocytes and hepatocytes. 46, 47) However, its functional role has not yet been determined. Tissue-specific TRPV1-null mice may be useful for clarifying the in vivo effects of TRPV1 in various target tissues.
TRPV1 and lipid metabolism
Several studies have shown that TRPV1 affects lipid metabolism. 48, 49) Our study demonstrated that TRPV1 channels were expressed in 3T3-L1-preadipocytes. high-fat-induced hypertriglyceridemia in rats on a high fat diet for 8 weeks. Tani et al. 49) revealed that after capsaicin administration, fatty acid synthase (FAS) activities were lower and hepatic triacylglycerol lipase (HTGL) activities tended to be higher than those fed a high-fat diet only.
Lipoprotein lipase (LPL) activity in adipose tissue was higher in the capsaicin than the high-fat diet group. Even though consumed for a short period, capsaicin can be a potent antioxidant and aid in lowering low-density lipoprotein (LDL) in rats. 50) The level of serum triglyceride in rats was lower when capsaicin was present in the high-fat diet than when it was not. However, levels of serum cholesterol and pre-beta-lipoprotein were not affected by the supplementation of capsaicin. These results suggest that capsaicin lowers serum triglyceride concentrations in lard-fed rats. 51) These effects may be due to its lipophilic characteristics, as capsaicin seems to have an important role in lipid metabolism. 50) Membrane lipid content can influence cellular TRPV1 channel distribution, localization, and function. Dietary intake of omega-3 fatty acids in humans is associated with a protective effect on cardiovascular health. 52) TRPV channels are an important class of omega-3 fatty acids targets. 53) It has been reported that omega-3 fatty acids differentially regulate TRPV1 in a phosphorylation-dependent manner. 53) Cholesterol depletion using methyl-β -cyclodextrin reduced TRPV1 protein levels in membrane fractions and TRPV1 mediated capsaicin and proton activated currents in adult rat dorsal root ganglion neurons. 54) These findings suggest that the dietary intake of lipids affects TRPV1 channels that are not directly involved in the regulation of circulating lipid levels.
TRPV1 and obesity
Obesity is a well-known risk factor for T2DM and CVD. Recently, increasing attention has been paid to the important roles of TRPV1 in obesity.
Studies show that CGRP from capsaicin-sensitive nerves plays a role in obesity. As discussed above, CGRP antagonizes insulin release and, in the long term, persistently high circulating CGRP levels cause insulin resistance and resultant obesity. 55) It is well documented that ablation of TRPV1-positive neurons by administration of a systemic agonist (capsaicin or resiniferatoxin, RTX) prevents the development of aging-associated insulin resistance.
56)
Motter et al. 57) found that disruption of the TRPV1 gene protects against diet-induced obesity. Furthermore, they also demonstrated that preadipocytes are sensitive to CGRP, thus revealing a potential neurogenic mechanism through which TRPV1-expressing neurons may regulate adipocyte function. Circulating CGRP levels increase during aging, and it was speculated that this phenomenon might play a crucial role in the development of insulin resistance and resulting obesity. Because TRPV1-expressing nerves are a major source of CGRP, TRPV1 antagonists might help prevent aging-associated insulin resistance and obesity.
However, once somatic small fiber neuropathy has developed in obese patients, it could be too late for TRPV1 antagonist therapy. 56) Obese patients show markedly reduced capsaicin-evoked flare responses in their skin that could be interpreted to imply downregulated TRPV1 expression and/or loss of TRPV1-positive nerve fibers. It is unclear whether or not the reduction of TRPV1 in obese subjects is due to down-regulation in response to high levels of CGRP. 58) Studies of both animals and humans implicated capsaicin is associated with energy expenditure and obesity prevention as a TRPV1 agonist. Several studies have
shown that acute oral capsaicin administration promotes oxygen consumption and fat utilization in rodents. 59, 60) Rodents fed a diet containing capsaicin, a dose equivalent to that ingested by rural Thai people, showed no change in caloric intake but a significant reduction in the visceral fat weight. 59 ) is widely expressed in the cardiometabolic system such as in pancreas, blood vessels, adipose tissue and liver. Activation of TRPV1 causes the relaxation of arteries leading to a decrease in blood pressure; increases the secretion of insulin from islet β cells and lowers blood glucose; improves insulin resistance; reduces inflammation, triglycerides, cholesterol, and adipogenesis; increases thermogenesis; and prevents obesity, implying that activation of TRPV1 will decrease cardiometabolic risk.
dietary capsaicin consumption prevented high-fat diet-induced obesity in WT mice, but not in TRPV1-null mice.
This study indicates that capsaicin may prevent adipogenesis and obesity through a direct action on TRPV1 channels in adipocytes. 11) Kanga et al. 37) showed that capsaicin could suppress obesity-induced inflammation through nuclear factor (NF)-κB inactivation and/or PPAR-γ activa- 
Summary
Emerging data indicate that TRPV1 plays an important role in cardiovascular and metabolic disease. As we reviewed before, the consumption of a capsaicin-rich diet may decrease cardiometabolic risk (Fig. 2) . Therefore, TRPV1 could be considered as a new therapeutic target for the management of cardiometabolic diseases. However, some questions remain to be elucidated in the future. First, the design and development of more specific agonists and antagonists for TRPV1 channels will promote research in this field. Next, interactions between TRPV1 and other TRP channels need to be studied in-depth.
